Organon & Co. Common Stock (OGN)
EBITDA Growth
-17.37%
Quarterly · Period ending:
OGN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-17.37%period ending
Latest reported-17.37%period ending
OGN Quarterly EBITDA YoY % (-44.69% → -17.37%)
Year-over-year change
High-resolution chart · PNG
OGN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -17.3719% | |
| 32.6861% | |
| -79.8246% | |
| 15.1741% | |
| 3.9352% | |
| -28.4722% | |
| 16.7235% | |
| 46.1818% | |
| -2.7027% | |
| 1.8868% | |
| 3.9007% | |
| -38.4787% | |
| 2.069% | |
| -28.3784% | |
| -28.7879% | |
| -17.0686% | |
| -19.7417% | |
| 17.2277% | |
| -30.2817% | |
| -27.4563% | |
| -29.1503% | |
| -44.6878% |